Back Home Up Next

 

 

 

 

Neurology/Psychiatry


 

 

  • The role of modafinil in treating disorders of excessive sleepiness. Review prepared April 2007. [FR, collaborating writer]

  • Series of 24 reports on regional advisory board meetings, and portions of 24 corresponding physician newsletters, regarding antipsychotic treatment of schizophrenia and bipolar disorder. Prepared December 2006 to April 2007. [BAC, writer]

  • Patient and physician perspectives on nonadherence with treatment for bipolar disorder: results of a multinational survey. Manuscript prepared November 2006. [FR, collaborating writer]

  • Implementation of stroke scales: impact on patient outcomes. Review prepared October 2006. [FR, collaborating writer]

  • Sleep problems (teaching slides for geriatrics residents). American Geriatrics Society, www.frycomm.com/ags/teachingslides, September 2006. [BAC and FR, writers]

  • 2 posters about modafinil-ADHD, prepared September 2006 for the American Academy of Pediatrics annual meeting. [FR, writer]

  • Current, new, and emerging treatment options in ADHD: focus on dosing & duration of effect. CME slide set prepared August 2006. [FR, writer]

  • An open-label study of the safety and clinical effectiveness of [a protocol] for treating methamphetamine dependence. Clinical trial report prepared June 2006. [FR, collaborating writer]

  • Using stroke scales to evaluate stroke severity and treatment effect. Review prepared June 2006. [FR, collaborating writer]

  • Behavioral problems in dementia (slide set). New York, NY: American Geriatrics Society, www.frycomm.com/ags/teachingslides, May 2005. [BAC and FR, collaborating writers]

  • Caley BA. Taking control: cancer patients deal with fear. CURE: Cancer Updates, Research and Education. 2006;5(3):64-68.

  • Gorman JM. Gender differences in depression and response to psychotropic medication. Gend Med. 2006;3:93-109. [FR, collaborating writer]

  • Qualitative message gap analysis about treatment of acute ischemic stroke, prepared April 2006. [FR, writer]

  • Smart choices can keep you smart [effect of lifestyle on cognitive function]. Prepared for Men’s Health Advisor, June 2005. [BAC, writer]

  • Medicine chest: Effexor, Cymbalta, and Remeron. Prepared for Men’s Health Advisor, June 2005. [BAC, writer]

  • Neurologic diseases and disorders (slide set). New York, NY: American Geriatrics Society, www.frycomm.com/ags/teachingslides, December 2004. [BAC and FR, editors]

  • Reidenbach F. New guidelines for choosing epilepsy medications. Cortlandt Forum. 2004;17(7):41-44.

  • Abnormalities of glucose metabolism associated with atypical antipsychotic drugs. Review prepared 2003. [FR, collaborating writer]

  • The pharmacoeconomics of acetylcholinesterase inhibitors for patients with dementia. Review prepared 2003. [FR, collaborating writer]

  • Report for a pharmaceutical company summarizing its clinical trials of an anti-migraine drug, prepared January 2003. [BAC and FR, researchers]

  • McCafferty F, Souryal S, McCafferty MA. The corruption process of a law enforcement officer: a paradigm of occupational stress and deviancy. J Am Acad Psychiatry Law. 1998;26:433-458. [FR, substantive editor]

  • Reidenbach F. A revolution in treatment for stroke. Cleveland Clin Heart Advisor. 1998:1(4):4-5.

  • Reidenbach F and Whitehouse PJ. Guidelines for early identification of Alzheimer disease. Alzheimer Dis Assoc Disorder. 1997;11:61-62.

  • Reidenbach F. General health care resources: neurology, neuroscience, and neurosurgery. In: Gibbs SR, Sullivan-Fowler M, Rowe NW, eds. Medical Surfari: A Guide to Exploring the Internet and Discovering the Top Health Care Resources. St. Louis: Mosby Year-Book; 1996.

  • Reidenbach F. Dental phobia and abuse survivors. Women’s Recovery Network. 1992;2(4):12-14.

  • Reidenbach F. What optometrists should know about attention-deficit hyperactivity disorder. Pediatric Optometry. 1992;2(2):8.

Bylined news reports distributed on Reuters Health wire service [FR, writer]:

  • Antagonism of gp120 might treat HIV-related cognitive impairment, 12-6-2002.

  • Mental health care lacking for depressed HIV-infected nursing home residents, 10-18-2002.

  • Central GABA function altered in women with premenstrual dysphoric disorder, 10-2-2002.

  • High baseline systolic BP predicts hemorrhage after streptokinase for stroke, 10-1-2002.

  • Reduced-dose flunarizine effective for migraine prophylaxis, 6-21-2002.

  • Often possible to detect autism cause, 3-14-2002.

  • Mental difficulties can persist long after chemotherapy, 2-11-2002.

  • Virtual reality therapy reduces hand impairment years after stroke, 2-1-2002.

  • Fever after bypass linked to mental difficulties, 1-31-2002.

  • Aricept benefits patients with vascular dementia, 1-28-2002.

  • Lower-status monkeys more likely to use cocaine, 1-21-2002.

  • Migraine more common in bipolar II than in other affective disorders, 1-21-2002.

  • Nerve damage possible with two arthritis drugs, 1-18-2002.

  • Anti-TNF-alpha therapy for arthritis linked to demyelinating CNS lesions, 1-16-2002.

  • Addition of cyclophosphamide could improve virus therapy for brain tumors, 7-27-1999.

  • Serotonin may mediate calming effect of stimulants in patients with ADHD, 1-15-1999.

  • Nortriptyline plus psychotherapy prevents recurrent depression in older patients, 1-6-1999.

  • Depression tied to cancer risk in elderly, 12-15-1998.

  • Triptans need not be first-line therapy for migraine, 11-11-1998.

  • Lorazepam more efficacious than phenytoin for overt status epilepticus, 9-17-1998.

  • Substance P antagonists have antidepressant, anxiolytic effects, 9-11-1998.

  • Genetic factors in Alzheimer’s disease have separate effects, 7-23-1998.

  • First neuron transplant performed for treatment of stroke, 7-9-1998.

  • Frovatriptan safe, efficacious against migraine in preliminary studies, 6-29-1998.

  • Severity of late-onset depression correlates with atrophy of prefrontal lobe, 6-23-1998.

  • Anticlotting drug doesn’t help stroke, 4-21-1998.

  • Future psychiatrists to study spirituality, 4-15-1998.

  • ADHD not overdiagnosed, 4-7-1998.

  • Many stroke survivors do well, 4-2-1998.

  • Age-related decline in dopamine affects motor, cognitive tasks, 3-16-1998.

Home • Bev Caley • Faith Reidenbach • Services • What We've Written • Client Experience • What Our Clients Say

 

Send mail to Bev@caleyreidenbach.com with questions or comments about this web site.
Last modified: 06/19/06